Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Colorectal Neoplasms

Free Subscription Articles published in BMC Cancer Retrieve available abstracts of 60 articles: HTML format Text format

Single Articles

March 2010
1. FUMAGALLI D , Gavin PG, Taniyama Y, Kim SI, et al
   A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes.
   BMC Cancer. 2010;10:101.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. REDANIEL MT , Laudico A, Mirasol-Lumague MR, Gondos A, et al
   Inter-country and ethnic variation in colorectal cancer survival: Comparisons between a Philippine population, Filipino-Americans and Caucasians.
   BMC Cancer. 2010;10:100.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
3. KLEIN-SCORY S , Kubler S, Diehl H, Eilert-Micus C, et al
   Immunoscreening of the extracellular proteome of colorectal cancer cells.
   BMC Cancer. 2010;10:70.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. LI L , Yu C, Gao H, Li Y, et al
   Argonaute proteins: potential biomarkers for human colon cancer.
   BMC Cancer. 2010;10:38.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
5. BAADE PD , Turrell G, Aitken JF
   A multilevel study of the determinants of area-level inequalities in colorectal cancer survival.
   BMC Cancer. 2010;10:24.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. EPPENBERGER M , Zlobec I, Baumhoer D, Terracciano L, et al
   Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer.
   BMC Cancer. 2010;10:93.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
7. GOETZE S , Feldhaus V, Traska T, Wolter M, et al
   ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma.
   BMC Cancer. 2009;9:447.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. CAO D , Hou M, Guan YS, Jiang M, et al
   Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications.
   BMC Cancer. 2009;9:432.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. COSTA-NOGUEIRA C , Villar-Portela S, Cuevas E, Gil-Martin E, et al
   Synthesis and expression of CDw75 antigen in human colorectal cancer.
   BMC Cancer. 2009;9:431.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. GODAI TI , Suda T, Sugano N, Tsuchida K, et al
    Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy.
    BMC Cancer. 2009;9:420.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
11. ANDERSEN V , Ostergaard M, Christensen J, Overvad K, et al
    Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) gene and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study.
    BMC Cancer. 2009;9:407.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. CASTILLEJO A , Mata-Balaguer T, Guarinos C, Castillejo MI, et al
    The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study.
    BMC Cancer. 2009;9:406.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. ABDULAMIR AS , Hafidh RR, Mahdi LK, Aljeboori T, et al
    Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma.
    BMC Cancer. 2009;9:403.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. SARVER AL , French AJ, Borralho PM, Thayanithy V, et al
    Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states.
    BMC Cancer. 2009;9:401.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
15. MATSUO K , Suzuki T, Ito H, Hosono S, et al
    Association between an 8q24 locus and the risk of colorectal cancer in Japanese.
    BMC Cancer. 2009;9:379.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. ARNDT GM , Dossey L, Cullen LM, Lai A, et al
    Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.
    BMC Cancer. 2009;9:374.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
17. LIEVRE A , Samalin E, Mitry E, Assenat E, et al
    Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study.
    BMC Cancer. 2009;9:347.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. KOSTOPOULOS I , Karavasilis V, Karina M, Bobos M, et al
    Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy.
    BMC Cancer. 2009;9:339.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
19. SCARTOZZI M , Bearzi I, Mandolesi A, Pierantoni C, et al
    Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis.
    BMC Cancer. 2009;9:303.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. SUN LC , Chu KS, Cheng SC, Lu CY, et al
    Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.
    BMC Cancer. 2009;9:288.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. WANG Q , Shen J, Li ZF, Jie JZ, et al
    Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer.
    BMC Cancer. 2009;9:287.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. HAWKES AL , Pakenham KI, Courneya KS, Gollschewski S, et al
    A randomised controlled trial of a lifestyle intervention for colorectal cancer survivors (CanChange): study protocol.
    BMC Cancer. 2009;9:286.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. MLAKAR V , Berginc G, Volavsek M, Stor Z, et al
    Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer.
    BMC Cancer. 2009;9:282.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. SZYBKA M , Zakrzewska M, Rieske P, Pasz-Walczak G, et al
    cDNA sequencing improves the detection of P53 missense mutations in colorectal cancer.
    BMC Cancer. 2009;9:278.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. ROTH ES , Fetzer DT, Barron BJ, Joseph UA, et al
    Does colon cancer ever metastasize to bone first? A temporal analysis of colorectal cancer progression.
    BMC Cancer. 2009;9:274.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
26. HONG YS , Cho HJ, Kim SY, Jung KH, et al
    Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancer.
    BMC Cancer. 2009;9:246.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. CHUNG FY , Huang MY, Yeh CS, Chang HJ, et al
    GLUT1 gene is a potential hypoxic marker in colorectal cancer patients.
    BMC Cancer. 2009;9:241.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. LANG K , Korn JR, Lee DW, Lines LM, et al
    Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis.
    BMC Cancer. 2009;9:227.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. DYDENSBORG AB , Teller IC, Groulx JF, Basora N, et al
    Integrin alpha6B beta4 inhibits colon cancer cell proliferation and c-Myc activity.
    BMC Cancer. 2009;9:223.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. CAMERON S , Huenerbein D, Mansuroglu T, Armbrust T, et al
    Response of the primary tumor in symptomatic and asymptomatic stage IV colorectal cancer to combined interventional endoscopy and palliative chemotherapy.
    BMC Cancer. 2009;9:218.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
31. DOHERTY GA , Byrne SM, Molloy ES, Malhotra V, et al
    Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer.
    BMC Cancer. 2009;9:207.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. SELZER-PLON J , Bornholdt J, Friis S, Bisgaard HC, et al
    Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis.
    BMC Cancer. 2009;9:201.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. CASTILLEJO A , Mata-Balaguer T, Montenegro P, Ochoa E, et al
    The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study.
    BMC Cancer. 2009;9:193.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. CHANG YS , Yeh KT, Chang TJ, Chai C, et al
    Fast simultaneous detection of K-RAS mutations in colorectal cancer.
    BMC Cancer. 2009;9:179.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
35. YANG SY , Bolvin C, Sales KM, Fuller B, et al
    IGF-I activates caspases 3/7, 8 and 9 but does not induce cell death in colorectal cancer cells.
    BMC Cancer. 2009;9:158.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. BALKO JM , Black EP
    A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer.
    BMC Cancer. 2009;9:145.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. SKOVBJERG H , Anthonsen D, Lothe IM, Tveit KM, et al
    Collagen mRNA levels changes during colorectal cancer carcinogenesis.
    BMC Cancer. 2009;9:136.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
38. SKOF E , Rebersek M, Hlebanja Z, Ocvirk J, et al
    Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial.
    BMC Cancer. 2009;9:120.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. SARFATI D , Hill S, Blakely T, Robson B, et al
    The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study.
    BMC Cancer. 2009;9:116.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. RAOUL JL , Van Laethem JL, Peeters M, Brezault C, et al
    Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study.
    BMC Cancer. 2009;9:112.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
41. KOELINK PJ , Lamers CB, Hommes DW, Verspaget HW, et al
    Circulating cell death products predict clinical outcome of colorectal cancer patients.
    BMC Cancer. 2009;9:88.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. FUJITA T , Ikeda H, Taira N, Hatoh S, et al
    Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer.
    BMC Cancer. 2009;9:87.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. LACEY JV JR , Kreimer AR, Buys SS, Marcus PM, et al
    Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort.
    BMC Cancer. 2009;9:84.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
44. WILSON S , Taskila T, Ismail T, Stocken DD, et al
    Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme.
    BMC Cancer. 2009;9:36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. THALHEIMER A , Otto C, Bueter M, Illert B, et al
    The intraportal injection model: a practical animal model for hepatic metastases and tumor cell dissemination in human colon cancer.
    BMC Cancer. 2009;9:29.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. JENSEN SA , Vainer B, Kruhoffer M, Sorensen JB, et al
    Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression.
    BMC Cancer. 2009;9:25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. SIEGEL R , Burock S, Wernecke KD, Kretzschmar A, et al
    Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society.
    BMC Cancer. 2009;9:50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. SACHDEV S , Bu Y, Gelman IH
    Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion.
    BMC Cancer. 2009;9:12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. JUNG B , Pahlman L, Johansson R, Nilsson E, et al
    Rectal cancer treatment and outcome in the elderly: an audit based on the Swedish Rectal Cancer Registry 1995-2004.
    BMC Cancer. 2009;9:68.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. SMITH E , Jones ME, Drew PA
    Quantitation of DNA methylation by melt curve analysis.
    BMC Cancer. 2009;9:123.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. CEN L , Hutzen B, Ball S, DeAngelis S, et al
    New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells.
    BMC Cancer. 2009;9:99.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. SVAGZDYS S , Lesauskaite V, Pavalkis D, Nedzelskiene I, et al
    Microvessel density as new prognostic marker after radiotherapy in rectal cancer.
    BMC Cancer. 2009;9:95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. BATHE OF , Ernst S, Sutherland FR, Dixon E, et al
    A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases.
    BMC Cancer. 2009;9:156.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. ZHANG XF , Zhang Y, Zhang XH, Zhou SM, et al
    Clinical significance of Neutrophil gelatinase-associated lipocalin(NGAL) expression in primary rectal cancer.
    BMC Cancer. 2009;9:134.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. ST HILL CA , Farooqui M, Mitcheltree G, Gulbahce HE, et al
    The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas.
    BMC Cancer. 2009;9:79.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. NIELSEN M , de Miranda NF, van Puijenbroek M, Jordanova ES, et al
    Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas.
    BMC Cancer. 2009;9:184.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. ARCE L , Pate KT, Waterman ML
    Groucho binds two conserved regions of LEF-1 for HDAC-dependent repression.
    BMC Cancer. 2009;9:159.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
58. KEKU TO , Sandler RS, Simmons JG, Galanko J, et al
    Local IGFBP-3 mRNA expression, apoptosis and risk of colorectal adenomas.
    BMC Cancer. 2008;8:143.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. VOISIN L , Julien C, Duhamel S, Gopalbhai K, et al
    Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.
    BMC Cancer. 2008;8:337.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. UCHIDA K , Danenberg PV, Danenberg KD, Grem JL, et al
    Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine.
    BMC Cancer. 2008;8:386.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: